Target intelligence / Profile preview

Neurofilament heavy polypeptide (NEFH)

Target
NEFH
Molecular classification
Intermediate filament protein, Cytoskeletal protein, Type IV intermediate filament
01

Overview

Neurofilament heavy polypeptide (NEFH) is a **type IV intermediate filament protein** and a core component of neurofilaments, which along with NEFL (light) and NEFM (medium) subunits, form the major cytoskeletal elements of neurons[2][5][6]. NEFH is essential for the **maintenance of neuronal shape and axonal caliber**, supporting fast axonal transport and contributing to the mechanical strength and stability of axons[2][5][6]. It is highly phosphorylated in axons, and its phosphorylation status modulates neurofilament spacing and axonal properties[2]. NEFH is not an enzyme, receptor, transporter, or typical pharmacological target, but instead is a **structural protein**. Mutations in NEFH are associated with **neurodegenerative diseases**, including Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (ALS)[3][5][7]. Levels of NEFH (or its phosphorylated forms) in cerebrospinal fluid or blood are widely used as a **biomarker** for neuronal injury and axonal degeneration in clinical and research settings[5][7].

Other names
Neurofilament heavy chainNEFHNFH200 kDa neurofilament proteinNeurofilament triplet H proteinNeurofilament heavyNeurofilament heavy polypeptide 200 kDaCMT2CC
02

Biological functions

Maintenance of axonal caliberStructural support of neuronal cytoskeletonIntracellular transport in axons/dendritesScaffold for axoplasmic constituents
03

Disease associations

Neurodegenerative disease (Amyotrophic lateral sclerosis, ALS)Peripheral neuropathy (Charcot-Marie-Tooth disease, type 2Cc)Indicator of neuronal injury
04

Biomarkers

Marker of neuronal damage (especially in ALS and other neurodegenerative disorders)Used in CNS injury assessment

Beyond the preview

Go deeper on Neurofilament heavy polypeptide (NEFH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurofilament heavy polypeptide (NEFH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call